The global Meningococcal Vaccine market size was US$ 285 million in 2024 and is forecast to a readjusted size of US$ 384 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.

Meningococcal Vaccine Sales Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.

In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

The global Meningococcal Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Meningococcal Vaccine Sales Market Report

Report Metric	Details
Report Name	Meningococcal Vaccine Sales Market
Forecasted market size in 2031	US$ 384 million
CAGR	4.4%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Meningtits A Polysaccharide Meningtitis AC Meningitis ACYW
By Application: (Core Demand Driver vs Emerging Opportunity)	6 Months-15Year over 3 Year over 2 Year over 3 Months
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Meningococcal Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Polysaccharide Meningtitis AC in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., over 3 Year in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Meningtits A dominance in Europe vs. Polysaccharide Meningtitis AC demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Meningococcal Vaccine Sales Market size in 2031?

Ans: The Meningococcal Vaccine Sales Market size in 2031 will be US$ 384 million.

What is the market share of major companies in Meningococcal Vaccine Sales Market?

Ans: Global top five players hold a share about 80%.

What is the Meningococcal Vaccine Sales Market share by type?

Ans: In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%.

Who are the main players in the Meningococcal Vaccine Sales Market report?

Ans: The main players in the Meningococcal Vaccine Sales Market are Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei

What are the Application segmentation covered in the Meningococcal Vaccine Sales Market report?

Ans: The Applications covered in the Meningococcal Vaccine Sales Market report are 6 Months-15Year, over 3 Year, over 2 Year, over 3 Months

What are the Type segmentation covered in the Meningococcal Vaccine Sales Market report?

Ans: The Types covered in the Meningococcal Vaccine Sales Market report are Meningtits A, Polysaccharide Meningtitis AC, Meningitis ACYW

1 Market Overview

1.1 Meningococcal Vaccine Product Scope

1.2 Meningococcal Vaccine by Type

1.2.1 Global Meningococcal Vaccine Sales by Type (2020 & 2024 & 2031)

1.2.2 Meningtits A

1.2.3 Polysaccharide Meningtitis AC

1.2.4 Meningitis ACYW

1.3 Meningococcal Vaccine by Application

1.3.1 Global Meningococcal Vaccine Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 6 Months-15Year

1.3.3 over 3 Year

1.3.4 over 2 Year

1.3.5 over 3 Months

1.4 Global Meningococcal Vaccine Market Estimates and Forecasts (2020-2031)

1.4.1 Global Meningococcal Vaccine Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Meningococcal Vaccine Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Meningococcal Vaccine Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Meningococcal Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Meningococcal Vaccine Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)

2.2.2 Global Meningococcal Vaccine Revenue Market Share by Region (2020-2025)

2.3 Global Meningococcal Vaccine Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Meningococcal Vaccine Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Meningococcal Vaccine Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Meningococcal Vaccine Market Size and Prospective (2020-2031)

2.4.2 Europe Meningococcal Vaccine Market Size and Prospective (2020-2031)

2.4.3 China Meningococcal Vaccine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Meningococcal Vaccine Historic Market Review by Type (2020-2025)

3.1.1 Global Meningococcal Vaccine Sales by Type (2020-2025)

3.1.2 Global Meningococcal Vaccine Revenue by Type (2020-2025)

3.1.3 Global Meningococcal Vaccine Price by Type (2020-2025)

3.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2026-2031)

3.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2026-2031)

3.2.3 Global Meningococcal Vaccine Price Forecast by Type (2026-2031)

3.3 Different Types Meningococcal Vaccine Representative Players

4 Global Market Size by Application

4.1 Global Meningococcal Vaccine Historic Market Review by Application (2020-2025)

4.1.1 Global Meningococcal Vaccine Sales by Application (2020-2025)

4.1.2 Global Meningococcal Vaccine Revenue by Application (2020-2025)

4.1.3 Global Meningococcal Vaccine Price by Application (2020-2025)

4.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2026-2031)

4.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2026-2031)

4.2.3 Global Meningococcal Vaccine Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Meningococcal Vaccine Application

5 Competition Landscape by Players

5.1 Global Meningococcal Vaccine Sales by Players (2020-2025)

5.2 Global Top Meningococcal Vaccine Players by Revenue (2020-2025)

5.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2024)

5.4 Global Meningococcal Vaccine Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Meningococcal Vaccine, Product Type & Application

5.7 Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Meningococcal Vaccine Sales by Company

6.1.1.1 North America Meningococcal Vaccine Sales by Company (2020-2025)

6.1.1.2 North America Meningococcal Vaccine Revenue by Company (2020-2025)

6.1.2 North America Meningococcal Vaccine Sales Breakdown by Type (2020-2025)

6.1.3 North America Meningococcal Vaccine Sales Breakdown by Application (2020-2025)

6.1.4 North America Meningococcal Vaccine Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Meningococcal Vaccine Sales by Company

6.2.1.1 Europe Meningococcal Vaccine Sales by Company (2020-2025)

6.2.1.2 Europe Meningococcal Vaccine Revenue by Company (2020-2025)

6.2.2 Europe Meningococcal Vaccine Sales Breakdown by Type (2020-2025)

6.2.3 Europe Meningococcal Vaccine Sales Breakdown by Application (2020-2025)

6.2.4 Europe Meningococcal Vaccine Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Meningococcal Vaccine Sales by Company

6.3.1.1 China Meningococcal Vaccine Sales by Company (2020-2025)

6.3.1.2 China Meningococcal Vaccine Revenue by Company (2020-2025)

6.3.2 China Meningococcal Vaccine Sales Breakdown by Type (2020-2025)

6.3.3 China Meningococcal Vaccine Sales Breakdown by Application (2020-2025)

6.3.4 China Meningococcal Vaccine Major Customer

6.3.5 China Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Business Overview

7.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Novartis Meningococcal Vaccine Products Offered

7.1.5 Novartis Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Business Overview

7.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.2.4 GSK Meningococcal Vaccine Products Offered

7.2.5 GSK Recent Development

7.3 Merck

7.3.1 Merck Company Information

7.3.2 Merck Business Overview

7.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Merck Meningococcal Vaccine Products Offered

7.3.5 Merck Recent Development

7.4 CSL

7.4.1 CSL Company Information

7.4.2 CSL Business Overview

7.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.4.4 CSL Meningococcal Vaccine Products Offered

7.4.5 CSL Recent Development

7.5 Baxter

7.5.1 Baxter Company Information

7.5.2 Baxter Business Overview

7.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Baxter Meningococcal Vaccine Products Offered

7.5.5 Baxter Recent Development

7.6 JN International Medical Corporation

7.6.1 JN International Medical Corporation Company Information

7.6.2 JN International Medical Corporation Business Overview

7.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered

7.6.5 JN International Medical Corporation Recent Development

7.7 Serum Institute of India

7.7.1 Serum Institute of India Company Information

7.7.2 Serum Institute of India Business Overview

7.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Serum Institute of India Meningococcal Vaccine Products Offered

7.7.5 Serum Institute of India Recent Development

7.8 Bio-Med

7.8.1 Bio-Med Company Information

7.8.2 Bio-Med Business Overview

7.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Bio-Med Meningococcal Vaccine Products Offered

7.8.5 Bio-Med Recent Development

7.9 China National Biotec Group

7.9.1 China National Biotec Group Company Information

7.9.2 China National Biotec Group Business Overview

7.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.9.4 China National Biotec Group Meningococcal Vaccine Products Offered

7.9.5 China National Biotec Group Recent Development

7.10 Hualan Bio

7.10.1 Hualan Bio Company Information

7.10.2 Hualan Bio Business Overview

7.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Hualan Bio Meningococcal Vaccine Products Offered

7.10.5 Hualan Bio Recent Development

7.11 Walvax

7.11.1 Walvax Company Information

7.11.2 Walvax Business Overview

7.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Walvax Meningococcal Vaccine Products Offered

7.11.5 Walvax Recent Development

7.12 Zhifei

7.12.1 Zhifei Company Information

7.12.2 Zhifei Business Overview

7.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Zhifei Meningococcal Vaccine Products Offered

7.12.5 Zhifei Recent Development

8 Meningococcal Vaccine Manufacturing Cost Analysis

8.1 Meningococcal Vaccine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Meningococcal Vaccine

8.4 Meningococcal Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Meningococcal Vaccine Distributors List

9.3 Meningococcal Vaccine Customers

10 Meningococcal Vaccine Market Dynamics

10.1 Meningococcal Vaccine Industry Trends

10.2 Meningococcal Vaccine Market Drivers

10.3 Meningococcal Vaccine Market Challenges

10.4 Meningococcal Vaccine Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

JN International Medical Corporation

Serum Institute of India

China National Biotec Group

List of Tables

Table 1. Global Meningococcal Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Meningococcal Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Meningococcal Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Meningococcal Vaccine Sales (10K Pcs) by Region (2020-2025)

Table 5. Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)

Table 6. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Meningococcal Vaccine Revenue Share by Region (2020-2025)

Table 8. Global Meningococcal Vaccine Sales (10K Pcs) Forecast by Region (2026-2031)

Table 9. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Meningococcal Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Meningococcal Vaccine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Meningococcal Vaccine Sales by Type (10K Pcs) & (2020-2025)

Table 13. Global Meningococcal Vaccine Sales Share by Type (2020-2025)

Table 14. Global Meningococcal Vaccine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Meningococcal Vaccine Price by Type (USD/Pcs) & (2020-2025)

Table 16. Global Meningococcal Vaccine Sales by Type (10K Pcs) & (2026-2031)

Table 17. Global Meningococcal Vaccine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Meningococcal Vaccine Price by Type (USD/Pcs) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Meningococcal Vaccine Sales by Application (10K Pcs) & (2020-2025)

Table 21. Global Meningococcal Vaccine Sales Share by Application (2020-2025)

Table 22. Global Meningococcal Vaccine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Meningococcal Vaccine Price by Application (USD/Pcs) & (2020-2025)

Table 24. Global Meningococcal Vaccine Sales by Application (10K Pcs) & (2026-2031)

Table 25. Global Meningococcal Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Meningococcal Vaccine Price by Application (USD/Pcs) & (2026-2031)

Table 27. New Sources of Growth in Meningococcal Vaccine Application

Table 28. Global Meningococcal Vaccine Sales by Company (10K Pcs) & (2020-2025)

Table 29. Global Meningococcal Vaccine Sales Share by Company (2020-2025)

Table 30. Global Meningococcal Vaccine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Meningococcal Vaccine Revenue Share by Company (2020-2025)

Table 32. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2024)

Table 33. Global Market Meningococcal Vaccine Average Price by Company (USD/Pcs) & (2020-2025)

Table 34. Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Meningococcal Vaccine, Product Type & Application

Table 36. Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Meningococcal Vaccine Sales by Company (2020-2025) & (10K Pcs)

Table 39. North America Meningococcal Vaccine Sales Market Share by Company (2020-2025)

Table 40. North America Meningococcal Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Meningococcal Vaccine Revenue Market Share by Company (2020-2025)

Table 42. North America Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)

Table 43. North America Meningococcal Vaccine Sales Market Share by Type (2020-2025)

Table 44. North America Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)

Table 45. North America Meningococcal Vaccine Sales Market Share by Application (2020-2025)

Table 46. Europe Meningococcal Vaccine Sales by Company (2020-2025) & (10K Pcs)

Table 47. Europe Meningococcal Vaccine Sales Market Share by Company (2020-2025)

Table 48. Europe Meningococcal Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Meningococcal Vaccine Revenue Market Share by Company (2020-2025)

Table 50. Europe Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)

Table 51. Europe Meningococcal Vaccine Sales Market Share by Type (2020-2025)

Table 52. Europe Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)

Table 53. Europe Meningococcal Vaccine Sales Market Share by Application (2020-2025)

Table 54. China Meningococcal Vaccine Sales by Company (2020-2025) & (10K Pcs)

Table 55. China Meningococcal Vaccine Sales Market Share by Company (2020-2025)

Table 56. China Meningococcal Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Meningococcal Vaccine Revenue Market Share by Company (2020-2025)

Table 58. China Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)

Table 59. China Meningococcal Vaccine Sales Market Share by Type (2020-2025)

Table 60. China Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)

Table 61. China Meningococcal Vaccine Sales Market Share by Application (2020-2025)

Table 62. Novartis Company Information

Table 63. Novartis Description and Business Overview

Table 64. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 65. Novartis Meningococcal Vaccine Product

Table 66. Novartis Recent Development

Table 67. GSK Company Information

Table 68. GSK Description and Business Overview

Table 69. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 70. GSK Meningococcal Vaccine Product

Table 71. GSK Recent Development

Table 72. Merck Company Information

Table 73. Merck Description and Business Overview

Table 74. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 75. Merck Meningococcal Vaccine Product

Table 76. Merck Recent Development

Table 77. CSL Company Information

Table 78. CSL Description and Business Overview

Table 79. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 80. CSL Meningococcal Vaccine Product

Table 81. CSL Recent Development

Table 82. Baxter Company Information

Table 83. Baxter Description and Business Overview

Table 84. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 85. Baxter Meningococcal Vaccine Product

Table 86. Baxter Recent Development

Table 87. JN International Medical Corporation Company Information

Table 88. JN International Medical Corporation Description and Business Overview

Table 89. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 90. JN International Medical Corporation Meningococcal Vaccine Product

Table 91. JN International Medical Corporation Recent Development

Table 92. Serum Institute of India Company Information

Table 93. Serum Institute of India Description and Business Overview

Table 94. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 95. Serum Institute of India Meningococcal Vaccine Product

Table 96. Serum Institute of India Recent Development

Table 97. Bio-Med Company Information

Table 98. Bio-Med Description and Business Overview

Table 99. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 100. Bio-Med Meningococcal Vaccine Product

Table 101. Bio-Med Recent Development

Table 102. China National Biotec Group Company Information

Table 103. China National Biotec Group Description and Business Overview

Table 104. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 105. China National Biotec Group Meningococcal Vaccine Product

Table 106. China National Biotec Group Recent Development

Table 107. Hualan Bio Company Information

Table 108. Hualan Bio Description and Business Overview

Table 109. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 110. Hualan Bio Meningococcal Vaccine Product

Table 111. Hualan Bio Recent Development

Table 112. Walvax Company Information

Table 113. Walvax Description and Business Overview

Table 114. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 115. Walvax Meningococcal Vaccine Product

Table 116. Walvax Recent Development

Table 117. Zhifei Company Information

Table 118. Zhifei Description and Business Overview

Table 119. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 120. Zhifei Meningococcal Vaccine Product

Table 121. Zhifei Recent Development

Table 122. Production Base and Market Concentration Rate of Raw Material

Table 123. Key Suppliers of Raw Materials

Table 124. Meningococcal Vaccine Distributors List

Table 125. Meningococcal Vaccine Customers List

Table 126. Meningococcal Vaccine Market Trends

Table 127. Meningococcal Vaccine Market Drivers

Table 128. Meningococcal Vaccine Market Challenges

Table 129. Meningococcal Vaccine Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Meningococcal Vaccine Product Picture

Figure 2. Global Meningococcal Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Meningococcal Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Meningtits A Product Picture

Figure 5. Polysaccharide Meningtitis AC Product Picture

Figure 6. Meningitis ACYW Product Picture

Figure 7. Global Meningococcal Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Meningococcal Vaccine Sales Market Share by Application in 2024 & 2031

Figure 9. 6 Months-15Year Examples

Figure 10. over 3 Year Examples

Figure 11. over 2 Year Examples

Figure 12. over 3 Months Examples

Figure 13. Global Meningococcal Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Meningococcal Vaccine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 15. Global Meningococcal Vaccine Sales (10K Pcs) Growth Rate (2020-2031)

Figure 16. Global Meningococcal Vaccine Price Trends Growth Rate (2020-2031) & (USD/Pcs)

Figure 17. Meningococcal Vaccine Report Years Considered

Figure 18. Global Market Meningococcal Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 19. Global Meningococcal Vaccine Revenue Market Share by Region: 2020 VS 2024

Figure 20. North America Meningococcal Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. North America Meningococcal Vaccine Sales (10K Pcs) Growth Rate (2020-2031)

Figure 22. Europe Meningococcal Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Europe Meningococcal Vaccine Sales (10K Pcs) Growth Rate (2020-2031)

Figure 24. China Meningococcal Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. China Meningococcal Vaccine Sales (10K Pcs) Growth Rate (2020-2031)

Figure 26. Global Meningococcal Vaccine Revenue Share by Type (2020-2025)

Figure 27. Global Meningococcal Vaccine Sales Share by Type (2026-2031)

Figure 28. Global Meningococcal Vaccine Revenue Share by Type (2026-2031)

Figure 29. Global Meningococcal Vaccine Revenue Share by Application (2020-2025)

Figure 30. Global Meningococcal Vaccine Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Meningococcal Vaccine Sales Share by Application (2026-2031)

Figure 32. Global Meningococcal Vaccine Revenue Share by Application (2026-2031)

Figure 33. Global Meningococcal Vaccine Sales Share by Company (2024)

Figure 34. Global Meningococcal Vaccine Revenue Share by Company (2024)

Figure 35. Global 5 Largest Meningococcal Vaccine Players Market Share by Revenue in Meningococcal Vaccine: 2020 & 2024

Figure 36. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Meningococcal Vaccine

Figure 38. Manufacturing Process Analysis of Meningococcal Vaccine

Figure 39. Meningococcal Vaccine Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions